- Home
- CVAC vs CRCT Comparison
CVAC vs CRCT Comparison
Compare CVAC & CRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CRCT
- Stock Information
- Founded
- CVAC 2000
- CRCT 1969
- Country
- CVAC Germany
- CRCT United States
- Employees
- CVAC N/A
- CRCT N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CRCT Wholesale Distributors
- Sector
- CVAC Health Care
- CRCT Industrials
- Exchange
- CVAC Nasdaq
- CRCT Nasdaq
- Market Cap
- CVAC 1.2B
- CRCT 1.4B
- IPO Year
- CVAC 2020
- CRCT 2021
- Fundamental
- Price
- CVAC $5.41
- CRCT $5.17
- Analyst Decision
- CVAC Hold
- CRCT Sell
- Analyst Count
- CVAC 3
- CRCT 3
- Target Price
- CVAC $6.83
- CRCT $4.52
- AVG Volume (30 Days)
- CVAC 974.0K
- CRCT 694.9K
- Earning Date
- CVAC 08-14-2025
- CRCT 08-05-2025
- Dividend Yield
- CVAC N/A
- CRCT 18.29%
- EPS Growth
- CVAC N/A
- CRCT 6.92
- EPS
- CVAC 0.87
- CRCT 0.31
- Revenue
- CVAC $566,039,775.00
- CRCT $707,780,000.00
- Revenue This Year
- CVAC N/A
- CRCT N/A
- Revenue Next Year
- CVAC $24.04
- CRCT $1.18
- P/E Ratio
- CVAC $6.26
- CRCT $16.78
- Revenue Growth
- CVAC 787.60
- CRCT N/A
- 52 Week Low
- CVAC $2.37
- CRCT $3.94
- 52 Week High
- CVAC $5.72
- CRCT $7.33
- Technical
- Relative Strength Index (RSI)
- CVAC 61.38
- CRCT 32.27
- Support Level
- CVAC $5.42
- CRCT $5.14
- Resistance Level
- CVAC $5.49
- CRCT $7.33
- Average True Range (ATR)
- CVAC 0.07
- CRCT 0.25
- MACD
- CVAC -0.06
- CRCT -0.20
- Stochastic Oscillator
- CVAC 52.38
- CRCT 6.62
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CRCT Cricut Inc.
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.